|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02633 JACOBSON PHARMA
Nominal 
0.650 +0.010 (+1.563%) | 2023/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | 2019/09 HKD(K$) | |
| Turnover | 714,918 | -12.533% | 817,353 | 750,413 | 695,425 | 871,686 |
| Cost of Sales | (413,839) | -13.227% | (476,924) | (477,571) | (429,168) | (513,169) |
| Gross Profit | 301,079 | -11.559% | 340,429 | 272,842 | 266,257 | 358,517 |
| 2023/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | 2019/09 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 332 | -- | (2,018) | (2,100) | (3,312) | 2,925 | |
| Profit / (Loss) before Taxation | 118,860 | -32.759% | 176,768 | 101,906 | 127,813 | 160,081 | |
| Taxation | (21,579) | -26.602% | (29,400) | (19,047) | (15,363) | (28,202) | |
| Profit / (Loss) from Discontinued Operations | 80,609 | -- | -- | -- | 3 | -- | |
| Non-controlling Interests | (23,850) | 113.404% | (11,176) | (2,820) | (9,940) | (4,661) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 154,040 | 13.105% | 136,192 | 80,039 | 102,513 | 127,218 | |
| 2023/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | 2019/09 HKD(K$) | |
| Net Finance Costs / (Income) | 31,510 | 66.192% | 18,960 | 11,984 | 14,491 | 27,770 |
| Depreciation & Amortisation | 71,403 | -22.983% | 92,711 | 97,582 | 88,952 | 86,165 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2023/09 - Interim | %Chg (Compare to Interim) | 2022/09 | 2021/09 | 2020/09 | 2019/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2023/09 - Interim | %Chg (Compare to Interim) | 2022/09 | 2021/09 | 2020/09 | 2019/09 | |
| EPS (cts) | 8.060 | 13.521% | 7.100 | 4.180 | 5.350 | 6.320 |
| DPS (cts) | 2.500 | -- | 2.800 | 1.200 | 0.800 | 2.000 |
| Dividend Payout Ratio (%) | 31.017% | -- | 39.437% | 28.708% | 14.953% | 31.646% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.179 | -- | 1.307 | 1.258 | 1.366 | 1.323 |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 266,968 |
| %Change | 6.343% |
| EPS / (LPS) | HKD 0.139 |
| NBV Per Share ($) | HKD 1.186 |